| 000 | 01428 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516230947.0 | ||
| 264 | 0 | _c20141121 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a1520-4995 | ||
| 024 | 7 |
_a10.1021/bi501007v _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Xuehong | |
| 245 | 0 | 0 |
_aCystic fibrosis transmembrane conductance regulator (CFTR) potentiators protect G551D but not ΔF508 CFTR from thermal instability. _h[electronic resource] |
| 260 |
_bBiochemistry _cSep 2014 |
||
| 300 |
_a5613-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAmino Acid Substitution |
| 650 | 0 | 4 |
_aAminophenols _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCystic Fibrosis _xdrug therapy |
| 650 | 0 | 4 |
_aCystic Fibrosis Transmembrane Conductance Regulator _xagonists |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutagenesis, Site-Directed |
| 650 | 0 | 4 |
_aMutant Proteins _xagonists |
| 650 | 0 | 4 |
_aOocytes _xmetabolism |
| 650 | 0 | 4 |
_aProtein Stability _xdrug effects |
| 650 | 0 | 4 |
_aQuinolones _xpharmacology |
| 650 | 0 | 4 |
_aRecombinant Proteins _xchemistry |
| 650 | 0 | 4 | _aTemperature |
| 650 | 0 | 4 | _aXenopus laevis |
| 700 | 1 | _aDawson, David C | |
| 773 | 0 |
_tBiochemistry _gvol. 53 _gno. 35 _gp. 5613-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/bi501007v _zAvailable from publisher's website |
| 999 |
_c24121968 _d24121968 |
||